Gain Therapeutics, Inc.GANXNASDAQ
LOADING
|||
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 5.97% |
| Q2 2025 | -16.48% |
| Q1 2025 | -31.17% |
| Q4 2024 | 25.29% |
| Q3 2024 | 45.51% |
| Q2 2024 | -86.92% |
| Q1 2024 | 0.67% |
| Q4 2023 | 9.78% |
| Q3 2023 | 36.81% |
| Q2 2023 | -47.83% |
| Q1 2023 | -14.66% |
| Q4 2022 | 3.99% |
| Q3 2022 | 8.22% |
| Q2 2022 | -57.41% |
| Q1 2022 | -2.48% |
| Q4 2021 | 30.78% |
| Q3 2021 | -31.91% |
| Q2 2021 | -42.47% |
| Q1 2021 | -52.69% |
| Q4 2020 | -97.25% |
| Q3 2020 | -53.83% |
| Q2 2020 | -3.94% |
| Q1 2020 | 26.28% |
| Q4 2019 | -32.35% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |